Metalloproteinases and Tissue Inhibitors in Generalized Myasthenia Gravis. A Preliminary Study
Introduction: Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) have recently been proposed as promising biomarkers in different immune-mediated disorders. We evaluated the plasma levels of MMP-9 and MMP-2 and their tissue inhibitors TIMP-1 and TIMP-2 in a patients...
Main Authors: | Vincenzo Di Stefano, Chiara Tubiolo, Andrea Gagliardo, Rosalia Lo Presti, Maria Montana, Massimiliano Todisco, Antonino Lupica, Gregorio Caimi, Cristina Tassorelli, Brigida Fierro, Filippo Brighina, Giuseppe Cosentino |
---|---|
Formato: | Artigo |
Idioma: | English |
Publicado: |
MDPI AG
2022-10-01
|
Series: | Brain Sciences |
Subjects: | |
Acceso en liña: | https://www.mdpi.com/2076-3425/12/11/1439 |
Títulos similares
-
Risk factors for postoperative myasthenia gravis in patients with thymoma without myasthenia gravis: A systematic review and meta-analysis
por: Mingbo Tang, et al.
Publicado: (2023-02-01) -
Role of complement in myasthenia gravis
por: Pyae Phyo San, et al.
Publicado: (2023-10-01) -
Inflammation and autoimmune myasthenia gravis
por: Ruksana Huda
Publicado: (2023-01-01) -
New Approaches to Targeting B Cells for Myasthenia Gravis Therapy
por: Ruksana Huda
Publicado: (2020-02-01) -
Myasthenia gravis and acetylcholine receptor antibodies: A clinico immunological correlative study on South Indian patients
por: Bindu P, et al.
Publicado: (2008-01-01)